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Driving under the influence is a major threat to road safety in South Africa. Various psychoactive 
substances (both licit and illicit) have the potential to adversely affect driving performance and 
increase the probability of a road traffic accident. While it is common practice in South Africa to 
test drivers for alcohol levels, testing for additional impairing substances (including drugs of abuse) 
is rarely performed. In terms of current South African legislation, only driving under the influence 
of alcohol and a ‘drug having a “narcotic” effect’ is prohibited. This excludes several impairing 
psychoactive drugs which are not classified as narcotic substances. The aim of this article is 
to highlight issues and/or limitations surrounding drugged driving and to propose appropriate 
considerations for revision of the National Road Traffic Act. We also recommend revising existing 
legislation to include a comprehensive statutory definition and detailed provisions for drug testing to 
deter impaired driving.
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Driving under the influence of drugs (DUID), also 
referred to as drugged driving or drug impaired 
driving, may be defined as the operation of 
a motor vehicle whilst under the influence of 
one or more psychoactive drugs.1 The latter 
includes both illicit and licit substances (e.g. 
central nervous system depressants, stimulants 
or hallucinogens), which have the potential to 
impair driving performance and pose a danger 
to public road users.2 
Road traffic injuries are a leading cause of 
preventable death in South Africa.3 In 2015, it 
was reported that road traffic injuries resulted in 
12 944 deaths (23.5 per 100 000 population) 
at a cost of approximately R143 billion to 
the state, communities and individuals.4 In 
addition, South Africa is faced with a continuing 
challenge regarding drug and alcohol abuse, 
INSTITUTE FOR SECURITY STUDIES & UNIVERSITY OF CAPE TOWN8
having the largest illegal drug market in sub-
Saharan Africa.5 The social and economic cost 
of illicit drug and alcohol abuse in the country 
has been estimated at 6.4% of the annual 
gross domestic product.6
Driving under the influence (DUI) is a major 
threat to road safety in South Africa, with 
the limited available statistics indicating that 
approximately 58% of road traffic fatalities 
involve alcohol (based on National Injury 
Mortality Surveillance System data from 2010).7 
However, the prevalence of road users in South 
Africa who use and/or abuse non-alcoholic 
impairing substances, which may impair driving 
ability, remains mostly unknown. This is primarily 
due to the little to no routine drug screening 
performed on drivers during random stops, and 
drivers who have been involved in accidents 
are seldom tested. This lack of screening and 
testing is exacerbated by the lack of regulated 
drug testing available in South Africa.8
Driving under the influence of alcohol and/
or drugs in South Africa is regulated by the 
National Road Traffic Act 93 of 1996 (NRTA/The 
Act) which states that:
No person shall on a public road – 
(a) drive a vehicle; or 
(b) occupy the driver’s seat of a motor 
vehicle the engine of which is running, 
while under the influence of intoxicating 
liquor or a drug having a narcotic effect.9
The Act also defines the legal limits for alcohol 
(ethanol) in the blood and breath of drivers and 
thereby sets the standard by which drivers 
can be charged or prosecuted for DUI of 
intoxicating substances. The wording of this law 
however raises substantial concern, as only 
‘narcotic’ drugs are mentioned, despite the 
fact that a vast number of impairing drugs 
(both medicinal and non-medicinal) do not fall 
within this classification. Examples of such 
non-narcotic drugs are illicit stimulants 
(crystal methamphetamine) or cannabis (delta-
9-tetrahydrocannabinol).
There is evidence to suggest that the 
prevalence of drugged driving may be as much 
of a concern as drunk driving. Results from 
the 2013–2014 National Roadside Survey in 
the United States found that the prevalence of 
impairing illegal drugs among weekend night-
time drivers was 15.2%, compared to 8.3% 
who tested positive for alcohol. Legal (over the 
counter and/or prescription) medications with 
impairing effects were detected (separately) in a 
further 7.3% of weekend night-time drivers.10
In a study carried out in South Africa in 
2008, drugs of abuse (excluding alcohol) 
were detected in 14% of drivers stopped at 
routine roadblock operations.11 This study 
concluded that only 76% of drivers under the 
influence were being detected under current 
enforcement procedures through breath 
alcohol roadside testing alone. This figure may 
well have changed substantially in the past 
decade as a result of altered patterns and 
prevalence of substance use.
The aim of this article is to highlight critical 
issues and limitations in the detection of 
drugged driving in South Africa and to propose 
appropriate revisions to the NRTA to more 
effectively detect and prevent drugged driving. 
Driving under the influence of alcohol
Alcohol is known to impair driving-related 
abilities, such as concentration, hand-eye 
coordination and reaction time.12 In South 
Africa, the NRTA states that it is illegal to drive 
while under the influence of an intoxicating 
liquor or when the blood alcohol concentration 
(BAC) or breath alcohol concentration (BrAC) 
is in excess of a specified level. Under 
current legislation, a non-professional driver 
is considered impaired if found to have a 
BAC ≥ 0.05 g/100 mL of blood13 or a BrAC 
≥0.24 mg/1000 mL of expired air.14 The 
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relationship between BAC and impairment has 
been well studied internationally. Research 
has shown that the risk of being involved in 
an accident increases significantly when the 
driver’s BAC is ≥ 0.05 g/100 mL, in comparison 
to drivers who have not been drinking.15 Levels 
in the same range are considered illegal in 
Australia, Belgium, France and Switzerland, 
among others.16
The NRTA also states that no person may refuse 
that a blood or breath specimen be taken for 
purposes of law enforcement. Traffic officers 
may stop any vehicle and request the driver 
to perform a preliminary breath test (PBT) for 
alcohol (an initial screening test). If the driver is 
found to be over the breath ethanol limit based 
on the screening test, officers may request that 
a blood sample be collected for confirmation. A 
laboratory confirmation of the BAC is required as 
evidence by the courts in order to prosecute an 
individual for DUI. Evidential breath testing (EBT) 
may also be conducted by law enforcement, 
using appropriate apparatus which requires 
strict maintenance and calibration to ensure 
reliable accuracy, precision and measurement 
uncertainty (in compliance with the requirements 
of the South African National Standard SANS 
1793:2013).17 In the past, the results obtained 
from EBT devices were permitted as evidence 
in court subject to compliance with all the 
relevant regulations, preconditions and further 
requirements relating to the EBT device. 
However, the reliability of results obtained from 
such a device was successfully disputed in 
S v Clifford Joseph Hendricks, where the Cape 
High Court ruled that results from certain types 
of breath alcohol testing apparatus (the Dräeger 
Alco test) were inadmissible for evidentiary 
purposes.18 At present, the use of these types of 
apparatus remain controversial in South Africa, 
and very few cases have been brought before 
the courts based on results generated using 
this equipment.  
Results obtained from tests conducted on 
patients who have been admitted to emergency 
rooms after sustaining injuries in road traffic 
accidents are seldom used in subsequent legal 
proceedings. This results from various factors, 
including breaks in the chain of custody, 
problems with the sample used for analysis and 
method of screening used. Hospital laboratories 
typically use serum samples with an enzymatic-
based alcohol testing.19 In the clinical setting, 
priority is given to attending to victims’ injuries, 
which means that the accuracy of the results 
obtained from the analyses performed in 
hospital or in clinical pathology laboratories may 
not hold up in court.20 It is routine practice at 
most South African medico-legal mortuaries 
to collect a blood sample at autopsy from 
fatally injured drivers for BAC analysis.21 Blood 
samples are, however, not routinely collected 
at autopsy and analysed for substances other 
than alcohol. Such additional screening is only 
done at the discretion and specific request 
of the attending forensic medical practitioner, 
and is used based on incidental information 
provided by law enforcement officials to 
suggest that such investigations are warranted. 
This additional incident information is frequently 
not available.
Driving under the influence of drugs
Assessing and interpreting the impairing effects 
of various drugs on driving is more complicated 
than with alcohol intoxication. Studies have 
reported that use of various psychoactive 
drugs, and/or a combination of two or more 
drugs, has the potential to adversely affect 
driving performance and increase the risk of a 
road traffic accident.22 These trends have been 
derived mostly from epidemiological research, 
relative risk studies and the prevalence of drug 
use in arrested and/or accident-involved (fatal 
and non-fatal) drivers.23
Results from the Driving Under the Influence 
of Drugs, Alcohol and Medicines (DRUID) 
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project in Europe indicate an increase in the 
relative risk of being seriously injured or killed 
when testing positive for drugs, particularly in 
the case of multiple drug use or drug use in 
combination with alcohol: a highly increased 
risk (5–30 times higher) was reported for 
amphetamines, followed by a medium increased 
risk (2–10 times higher) for cocaine, illicit opiates, 
benzodiazepines, sedatives and medicinal 
opioids.24 This report notes, however, that some 
of the risk estimates were based on few positive 
cases and/or controls, which resulted in wide 
confidence intervals. Although non-alcohol drugs 
are associated with an increased probability 
of being involved in an accident, the risk in 
most cases is considered low to moderate for 
individual drugs.25 However, the risk is greatly 
increased when the substance is taken in 
combination with alcohol or other drugs.26
In Australia, Drummer et al conducted a 
multi-centre case control study on fatally 
injured drivers (n = 3398) in which a significant 
association with crash culpability was observed 
in cases where drug/s (licit or illicit) were 
detected at post mortem (odds ratio = 1.7).27 
It was also found that drivers testing positive 
for tetrahydrocannabinol (THC) combined with 
alcohol (BAC ≥ 0.05 g/100mL), were 2.9 times 
more likely to be responsible for the crash in 
comparison with drug-free drivers with BACs 
≥ 0.05 g/100mL.28 Ogden et al reported in 
Victoria (Australia) that 75% of injured drivers 
testing positive for one drug, 77% for two drugs, 
93% for three drugs and 100% of those testing 
positive for four drugs, were determined to be 
responsible for the accident.29 
Existing research on drugged driving, conducted 
in countries such as Australia, Sweden, Spain 
and the United States, has shown that drugs 
of abuse are present in the body fluids (mostly 
blood) of 8.8% to 39.6% of fatally injured 
drivers.30 This is clearly a pervasive problem the 
world over.
Drug-related impairment
Despite growing evidence that many drugs 
impair critical driving skills, it is still challenging 
to accurately demonstrate the correlation 
between the presence of a drug in the body 
and an associated level of impairment. 
This means that drugged driving is seldom 
successfully identified or prosecuted.31 DuPont 
et al identify three general classifications of 
drugs that can impair driving (according to 
the scheduling status of the South African 
Medicine and Related Substances Act 101 
of 1965):32
i)  Controlled or illegal substances 
(Schedule 7 and 8) that are commonly 
abused. These include heroin, 
methylenedioxymethamphetamine 
(MDMA), cannabis, methaqualone or 
gamma-hydroxybutyrate (GHB). Access 
to these highly addictive drugs is tightly 
controlled, and it is an offence to be in 
possession of these drugs without an 
appropriate permit.33 
ii) Prescription medications typically include 
Schedule 3, 4, 5 and 6 substances, which 
include opioids such as oxycodone, 
methadone and buprenorphine as well 
as benzodiazepines such as alprazolam, 
clonazepam and diazepam. These 
medications have approved medical 
uses and may only be prescribed by a 
physician, but are frequently misused 
and/or abused and taken without a 
prescription or for ulterior purposes.
iii) Certain medicines can be sold over the 
counter (OTC), without a prescription and 
include Schedule 0, 1 and 2 drugs. These 
drugs, although not commonly abused, 
may have the ability to cause sedation, 
such as with most antihistamines. 
Although attempts have been made to 
assess the relationships between drug and/
11SA CRIME QUARTERLY NO. 67 • MARCH 2019
or drug metabolite concentrations in biological 
samples and levels of impairment, this 
evidence remains unclear.34 Establishing drug 
impairment thresholds (similar to BAC limits), 
is complicated by the wide range of drugs 
available, the infinite number of drug-drug and 
drug-alcohol combinations, as well as their 
complex physicochemical, pharmacokinetic 
and pharmacodynamic properties.35 Analytical 
factors that influence the determination of 
drug levels may include the detection limit of 
the particular analytical technique used, the 
chemical properties of the drug and the type of 
sample used.36
A detectable concentration of a drug in testing 
does not necessarily imply impairment at the 
time of driving, as detection times vary for 
different substances and between biological 
matrices.37 The duration of detection depends 
on the dosage, the route of administration, 
acute versus chronic use and individual 
variation in metabolism. Individual tolerance 
plays a significant role in the level of impairment 
as chronic drug users require increased 
dosages to produce the desired effect.38 Other 
individual variances that play a role include, 
among others, the rate of drug metabolism 
(slow, rapid/ultra-rapid metaboliser), age, 
gender and state of health. The degree of 
impairment also depends on whether the 
individual is experiencing acute intoxication 
or withdrawal.39 Additional variables that may 
affect driving performance specifically are, 
among others, the level of fatigue, the driver’s 
age and driving experience, time of day, and/or 
environmental distractions.40
International legislation pertaining to 
driving under the influence of drugs
Per se standards, which make it a DUI 
offence to drive with a measured quantity 
of certain drugs in one’s system, are often 
used in legislation to address drug impaired 
driving.41 There are generally two types of per 
se standards: zero-tolerance drugged driving 
laws (which are defined according to the limits 
of detection using valid and reliable laboratory 
methods)42 and per se laws that stipulate 
non-zero thresholds for drugs or their 
metabolites, which constitute evidence of 
drugged driving.43 The application of these 
per se laws, therefore, make it illegal to drive a 
vehicle with a specified level of a drug present 
in a certain specimen obtained from the body, 
or in fact the mere detection of the drug itself, 
with no further evidence of impairment (or lack 
thereof) required.44
Per se laws pertaining to driving under the 
influence of drugs other than alcohol, are 
practiced in many countries including the 
US, Canada, Australia, New Zealand, United 
Kingdom (UK) and certain Western European 
nations, such as Belgium, Finland, Sweden 
and France.45 As of April 2017, 22 states in the 
US had adopted per se laws for DUID other 
than alcohol, seven of which specify non-zero 
thresholds for certain drugs.46 Sixteen states 
have zero tolerance laws, where any (reliably) 
measured presence of a controlled substance 
in the body while driving is an offence. There 
is some variation regarding the marijuana 
impairment driving laws in certain states, 
due to their different legalisation status.47 All 
Australian states have laws prohibiting the 
operation of a vehicle while under the influence 
of methamphetamine, MDMA or ecstasy 
and THC.48 In the UK, new drugged driving 
legislation was promulgated as of March 
2015 in England and Wales, which stipulates 
drug thresholds in blood for eight commonly 
abused drugs, as well as certain prescription 
medications.49
How legislation is enforced, and the penalties 
associated with an offence differ across 
countries. The World Health Organisation (WHO) 
sets out a framework for the management 
of DUID,50 which requires establishing the 
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legal framework for DUID laws, testing for the 
presence of drug use (such as roadside testing), 
enforcement of the laws, raising awareness to 
the effects of DUID, as well as counselling and/
or support for offenders.51 
The management of DUID in South Africa 
should address all areas contained in the 
WHO policy brief.52 Arrive Alive is a well-
known on-line road safety awareness 
programme in South Africa, which could be 
used as a forum to create awareness of DUID 
and promote the proposed legislation and 
enforcement strategies.53
Testing for drugged driving 
in South Africa 
The laboratory analysis of biological samples for 
drugs of abuse (especially for law enforcement 
purposes) is costly and may involve a 
considerable delay in obtaining results. Drug 
testing procedures need to be as efficient and 
cost effective as possible and results must 
be accurate and able to withstand scrutiny in 
an adversarial legal system. Blood and urine 
are the most commonly used specimens 
in toxicological investigations.54 A blood 
specimen is considered the best specimen 
for confirmatory analysis in DUI investigations 
due to the short detection period.55 There 
are also distinct advantages of utilising blood 
specimens in terms of the wide variety of 
analytical methodologies available, numerous 
published reference data for both ante mortem 
and post mortem drug concentrations, 
short detection periods and the quantitative 
or interpretive value.56 There are, however, 
drawbacks for these biological matrices. For 
example, collection of blood is invasive and 
typically requires transporting a suspect to 
a clinic to collect a sample, whilst urine has 
limited quantitative value as the detection 
times for drugs or metabolites are very variable 
(from a few hours up to a month). The positive 
identification of a substance in urine therefore 
only indicates exposure to the particular 
substance, and is not necessarily related 
to impairment.57
Oral fluid (saliva) sampling offers certain 
advantages over blood and urine for DUI 
investigations. It is minimally invasive and can 
indicate recent use proximate to the time of 
driving.58 Oral fluid screening technology is 
advancing and testing devices are becoming 
more robust and reliable.59 Several countries 
now use these testing devices to screen for 
drugs of abuse.60 Although these devices can 
provide a preliminary result, oral fluid screening 
is not evidential in nature and may still 
frequently yield false negative or false positive 
results. Confirmatory analysis is therefore 
mandatory in forensic investigations. Oral fluid 
screening devices have previously been tested 
in South Africa during standard roadblocks.61 
Drugs were detected in 14% of the 269 drivers 
who were tested, and both alcohol and drugs 
in 5% of cases. Based on the ease of use and 
accuracy, roadside oral fluid testing devices 
have the potential to assist law enforcement to 
reduce drug-impaired driving in South Africa.62
There is much debate on whether the mere 
presence of a drug(s) is substantial enough to 
suggest impairment, or whether it is necessary 
to quantitate the levels of a drug. Per se laws, 
or more specifically zero-tolerance laws, 
could be rationalised for illicit drugs – since 
if possession is illegal, it is reasonable to 
prohibit driving under the influence thereof.63 
The same does not apply to impairing licit 
drugs (prescription and/or over the counter 
medications). Implementing per se limits for licit 
drugs is not as straightforward as legitimate 
medical use (with a valid prescription) of 
certain medications, which can also result in 
impairment.64 Appropriate precautions and/or 
penalties should therefore be considered 
for drivers under the influence of certain 
medications based on whether they are in 
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presence of drugs, nor the medical evidence 
required to prove positive detection and 
impairment. In order to prevent drugged driving, 
as well as successfully identify and prosecute 
individuals who do so in South Africa, important 
revisions to existing legislation and detection 
strategies are required. Although it will be the 
responsibility of the state law advisers to draft 
this legislation, input and guidance should 
be sought from appropriate medical and/or 
scientific experts, particularly from forensic 
toxicologists, which is currently a growing 
discipline in South Africa. 
Currently, the NRTA does not provide a 
definition for the term ‘narcotic” in the list of 
definitions of the Act.70 No specific provision is 
made to define or to prevent driving whilst under 
the influence of other substances (medicinal 
or non-medicinal, licit or illicit) which may 
predispose the driver to dangerous situations 
or have a detrimental effect on the overall 
ability to safely operate a vehicle on the roads. 
Included here would be a variety of non-
narcotic substances that may compromise the 
cognitive functioning (including, for example, 
by inducing recklessness and/or risk taking) or 
impair the sensory and motor capacity required 
to negotiate traffic situations. The NRTA also 
needs to include comprehensive and inclusive 
statutory restrictions and limitations applicable 
to driving while using impairing non-alcohol 
substances, based on medical, pharmacological 
and legal guidance. The Act should also include 
an adequate legal definition for the term ‘drug.’
Cases of drugged driving must be more 
successfully identified and processed by law 
enforcement, as the failure to do so can have 
devastating effects. The case of S v Katlego 
M Maarohanye and co-accused Themba 
Tshabalala provides an example of this impact. 
The accused were found guilty of driving under 
the influence of cocaine, causing an accident 
that killed four school children.71
possession of a valid prescription; whether 
the medication is being used as prescribed by 
the physician or pharmacist (conforming with 
warnings or guidelines pertaining to driving), and 
not used in combination with other impairing 
substances (e.g. alcohol or illicit drugs).65 
According to the WHO, 159 countries have 
legislation regarding DUID but the majority 
of these laws lack a proper definition for 
what is classified as a drug.66 It may thus be 
appropriate, in the South African setting, to 
establish a working committee in order to define 
which drugs to prohibit while driving and to 
decide if per se or zero-tolerance limits should 
be adapted. The suggested penalties if a driver 
is found guilty should also be set. 
Forensic testing of biological samples for 
DUI cases is the responsibility of the National 
Department of Health Forensic Chemistry 
Laboratories (FCL). Unfortunately, these 
laboratories are already beyond capacity with 
a much-publicised backlog and may lack the 
capability to render additional adequate forensic 
toxicology/analytical services.67 Additionally, not 
all FCLs are accredited by the South African 
National Accreditation System, which aims to 
ensure formal recognition and competence in 
line with international standards based on the 
relevant ISO 17025 requirements.68 Suboptimal 
storage conditions and delays in analyses of 
samples may also compromise the validity of 
test results and their use in courts of law.69
Recommendations for reform 
in South Africa
Very few cases of drugged driving, outside 
of that of alcohol intoxication, are identified 
or pursued under current legislation and law 
enforcement strategies. There is no specific 
legislation that prescribes limitations pertaining 
to driving whilst under the influence of a drug 
other than a narcotic substance, but which may 
nonetheless impair driving ability. The NRTA 
also makes no provision for determining the 
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Although per se legislation makes prosecuting 
drugged drivers more efficient and effective, 
the vast number of potentially impairing 
drugs and the numerous combinations and 
interactions between them makes it difficult to 
set limits (like the 0.05 g/100 mL BAC limit for 
alcohol) for all drugs of abuse.72 Implementing 
non-zero thresholds may also lead to a public 
perception that driving under the influence of 
illegal drugs is acceptable to a certain degree. 
To enable the proper implementation of per se 
standards, the public must be made 
aware of the risks and consequences of 
impairment, especially when driving while 
under the influence of prescription drugs. This 
public awareness campaign must also include 
adequate information and precautions, for 
example, through appropriate drug labelling, 
and physician and/or pharmacist counselling.73
More efficient and accurate drug testing could 
also lead to improvements in the detection, 
prosecution and conviction of drugged 
drivers.74 To enable this, standards should 
be set for the biological matrices authorised 
for drug analysis, specification of the 
substances that should be tested for during 
analysis, cut off concentrations should be 
established for different substances, and the 
circumstances under which drug testing should 
be conducted should be clarified. Standard 
operating procedures need to be defined for 
the acquisition, storage, quality control and 
analysis of specimens. To ensure successful 
prosecution of drugged drivers, it is vital that 
these analyses be conducted at an accredited 
facility, by fully trained forensic analysts.
Clear protocols – similar to those already in 
place for alcohol – must be established for 
police to follow when testing and obtaining 
specimens from drivers who are under the 
influence of drugs. Drugged driving detection 
and enforcement should be aligned with 
procedures developed for alcohol impaired 
driving. This could be accompanied by roadside 
clinical assessment programmes or providing 
officers with training on identifying drug 
impairment symptoms in drivers, as is practiced 
by Drug Recognition Experts (DREs) in certain 
parts of the US.75
Forensic mortuaries should also implement a 
prescriptive protocol for the routine testing of 
biological samples obtained at autopsy from fatally 
injured drivers for the presence of substances 
other than just alcohol.76 This protocol should use 
a ‘targeted’ approach to identify those substances 
which may commonly be abused in a particular 
society. Along with regular random roadside 
testing, this could provide valuable insight into 
the prevalence and demographics of drug use by 
drivers in the general population. This information 
could foundation prevention strategies, as well 
as align with resolutions addressed in the 2013–
2017 National Drug Master Plan (NDMP).77 The 
additional costs incurred by such extended testing 
programmes may be justified by the benefits that 
may accrue from an improved understanding 
of the scope and nature of the problem of drug 
abuse in South Africa, as well as the improved 
administration of justice.   
Expert medical evidence is very seldom led 
by prosecutors in cases of alleged drugged 
driving in South Africa: physicians at emergency 
medical facilities rarely do formal assessments 
of injured patients with respect to possible drug 
and/or alcohol induced impaired driving ability 
– and even less frequently formally and properly 
document these findings contemporaneously in 
patient records.78 Physicians and nurses should 
be trained and mandated to do the clinical (and 
laboratory) assessments required to recognise, 
identify and chart the effects of drugs and alcohol. 
Additional training should be done to ensure that 
medical staff are aware of their ethical and legal 
obligations in these cases, and are familiar with 
the provisions of the Criminal Procedure Act 51 
of 1977.
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Conclusion
At present, our knowledge of the extent of 
drugged driving in South Africa is very limited. 
More studies should be conducted in South 
Africa to adequately define the problem and 
to provide accurate data to underpin policy 
initiatives and resource allocation. Additionally, 
operational protocols to identify drugged 
drivers need to be defined, encompassing 
aspects that extend from the roadside to the 
clinical or mortuary setting and the analytical 
environment. These protocols should be based 
on principles of cost effectiveness (in a resource 
constrained society) as well as scientifically 
robust methodologies, in order to withstand 
inevitable intense scrutiny in our adversarial 
legal system. Field sobriety testing and oral 
fluid screening, using state of the art devices, 
should be considered for routine (screen) 
detecting of drugged driving at the roadside and 
in emergency rooms. Specific and appropriate 
clinical assessments by trained medical and 
nursing professionals should be routinely 
performed on injured drivers – and the results 
should be competently and contemporaneously 
recorded. Provisions also need to be made to 
include standardised protocols for obtaining 
blood samples for confirmatory analyses and 
associated laboratory methodologies that would 
serve admissible in court. It is then vital to 
enhance laboratory capacities for toxicological 
testing and designate appropriate facilities to 
efficiently render these analytical services.
Existing legislation must be revised, guided by 
appropriate scientific expertise. The adoption 
of per se laws pertaining to drugged driving 
may be in the best interest of public safety. 
Legislation that requires routine drug testing for 
certain drugs (other than alcohol) and defines 
the analytical parameters and required evidence 
for prosecution may deter drugged driving and 
enhance the successful prosecution of drug 
impaired drivers. These efforts should target 
known, problematic and/or commonly abused 
substances in South Africa as a starting point.
Interventions such as regular random roadside 
testing and mandatory testing of drivers involved 
in accidents are necessary to establish the 
extent and profile of drug and alcohol impaired 
driving in South Africa. An integrated approach 
of support and collaboration is necessary 
between relevant participating role players (law 
enforcement agencies, health care workers and 
medical professionals, forensic scientists as well 
as prosecutorial authorities) in order to revise 
existing legislation and develop a standardised 
and realistic protocol-driven approach to reduce 
drug impaired driving in South Africa. 
These proposed measures would undoubtedly 
have substantial additional cost implications. 
However, these costs (of setting up working 
committees, revised training of law enforcement 
officers, health care workers and prosecuting 
authorities, as well as increased analytical 
costs), must be weighed against the benefits 
to society, and the economic and social burden 
of drugged driving-related road traffic injuries 
in South Africa. Perhaps the right question is 
not whether the country can afford such an 
increased fiscal burden, but whether we can 
afford not to? 
To comment on this article visit 
http://www.issafrica.org/sacq.php
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